Christophe Roberge
Chief Tech/Sci/R&D Officer chez MEDINCELL S.A.
Profil
Christophe Roberge is currently working as a Technical Director at MedinCell SA since 2008.
Prior to this, he worked as a Director-Process Development & Industrialization at BioArtificial Gel Technologies, Inc. from 2003 to 2008.
Mr. Roberge holds a doctorate degree from Institut National de la Recherche Scientifique.
Postes actifs de Christophe Roberge
| Sociétés | Poste | Début |
|---|---|---|
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 01/05/2016 |
Anciens postes connus de Christophe Roberge
| Sociétés | Poste | Fin |
|---|---|---|
BioArtificial Gel Technologies, Inc.
 BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | 01/01/2008 |
Formation de Christophe Roberge
| Institut National de la Recherche Scientifique | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Health Technology |
